Dimethyloxaloylglycine (DMOG)

Dimethyloxaloylglycine (DMOG)__Prolyl-4-hydroxylase inhibitor Otamixaban

Product Name Dimethyloxaloylglycine (DMOG)
Description

Prolyl-4-hydroxylase inhibitor

Purity >99%
CAS No. 89464-63-1
Molecular Formula C6H9NO5
Molecular Weight 175.1
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (>25 mg/ml), 100% ethanol (>25 mg/ml) or dimethyl formamide, or PBS pH7.2 (10 mg/ml)
Source Synthetic
Appearance Off-white solid
SMILES C(C(=O)OC)NC(C(=O)OC)=O
InChI InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9)
InChIKey BNJOZDZCRHCODO-UHFFFAOYSA-N
Safety Phrases Classification: Caution. Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25 – Avoid contact with skin and eyes
Hazard Statements:
H302 – Harmful if swallowed
Cite This Product Dimethyloxaloylglycine (DMOG) (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-382)

References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19120509

Alternative Names DMOG, N-(Methoxyoxoacetyl)-glycine methyl ester
Research Areas Cell Signaling
PubChem ID 560326
Scientific Background DMOG is a cell permeable prolyl-4-hydroxylase inhibitor which upregulates HIF activity. HIF activation stimulates angiogenesis in several different models. DMOG also inhibits FIH (Factor Inhibiting HIF), an asparaginyl hydroxylase, which enhances the HIF response. It is active in vivo and attenuates myocardial injury in a rabbit ischemia reperfusion model (20mg/kg). Is expected to act pro-angiogenic.
References 1. Grozinger C.M., et al. (2001) J. Biol. Chem. 276(42): 38837-43.
2. Mai A., et al. (2005) J. Med. Chem. 48(24): 7789-95.
3. Kahyo T., et al. (2008) J. Pharmacol. Sci. 108(3): 364-71.
4. Jung-Hynes B., et al. (2009) J. Biol. Chem. 284(6): 3823-32.